Croatia vs Cyprus: HIV/AIDS deaths averted by antiretroviral therapy
Croatia
62.42 deaths
in 2024
Cyprus
64 deaths
in 2021
Croatia rank
132nd
Cyprus rank
131st
HIV/AIDS deaths averted by antiretroviral therapy over time
- Croatia
- Cyprus
How they compare
Cyprus currently reports 64 deaths against 62.42 deaths in Croatia, a difference of 1.58 deaths.
The two have swapped places 2 times across 32 shared years of data; in 1990 it was Cyprus ahead.
Croatia ranks 132nd and Cyprus ranks 131st of 157 countries.
Across the 4 decades both report, Croatia averaged higher in 3 and Cyprus in 1.
Head to head by decade
| Decade | Croatia | Cyprus | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 5.5 deaths | 0 deaths | 5.5 deaths | Croatia |
| 2000s | 30.97 deaths | 11.5 deaths | 19.47 deaths | Croatia |
| 2010s | 54.21 deaths | 42.1 deaths | 12.11 deaths | Croatia |
| 2020s | 60.73 deaths | 63.5 deaths | 2.77 deaths | Cyprus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Croatia or Cyprus?
- Cyprus, at 64 deaths against 62.42 deaths in Croatia as of 2021.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Croatia and Cyprus?
- 1.58 deaths, with Cyprus ahead.
- How many years of comparable data are there for Croatia and Cyprus?
- 32 years are reported by both, from 1990 to 2021.
- How do Croatia and Cyprus rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Croatia ranks 132nd and Cyprus ranks 131st of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.